Character Virulence Association Factors and Gene Mutation Mediating Multidrug Resistance Phenotypes in Candidozyma duobushaemulonii

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Mycopathologia

• Publication date

  2025-10-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11046-025-01008-7PMID 41042413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative analyses of the biological characteristics, fluconazole resistance, and heat adaptation mechanisms of Candida auris and members of the Candida haemulonii complex

  2025cited by this paper
• Rapid in vitro evolution of flucytosine resistance in Candida auris

  2025cited by this paper
• Molecular characterization of some multidrug resistant Candida Auris in egypt

  2025cited by this paper
• The multidrug-resistant Candida auris, Candida haemulonii complex and phylogenetic related species: Insights into antifungal resistance mechanisms

  2025cited by this paper
• Genetic and Phenotypic Intra-Clade Variation in Candida auris Isolated from Critically Ill Patients in a New York City Tertiary Care Center.

  2025cited by this paper
• New pharmacotherapeutic strategies for drug-resistant Candida infections: a review

  2024cited by this paper
• Genetic Mutations in FKS1 Gene Associated with Acquired Echinocandin Resistance in Candida parapsilosis Complex

  2024cited by this paper
• Optimizing the Treatment of Invasive Candidiasis—A Case for Combination Therapy

  2024cited by this paper
• Candida haemulonii Complex and Candida auris: Biology, Virulence Factors, Immune Response, and Multidrug Resistance

  2023cited by this paper
• Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1

  2023cited by this paper
• Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species

  2023cited by this paper
• Comparative analysis of the biological characteristics and mechanisms of azole resistance of clinical Aspergillus fumigatus strains

  2023cited by this paper
• The safety of oral antifungals for the treatment of onychomycosis

  2023cited by this paper
• Cell Aggregation Capability of Clinical Isolates from Candida auris and Candida haemulonii Species Complex

  2023cited by this paper
• Antifungal Effect of Vitamin D3 against Cryptococcus neoformans Coincides with Reduced Biofilm Formation, Compromised Cell Wall Integrity, and Increased Generation of Reactive Oxygen Species

  2023cited by this paper
• Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies.

  2023cited by this paper
• Development and Validation of TaqMan Chemistry Probe-Based Rapid Assay for the Detection of Echinocandin-Resistance in Candida auris

  2023cited by this paper
• Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries

  2022cited by this paper
• Antifungal activity of vitamin D3 against Candida albicans in vitro and in vivo.

  2022cited by this paper
• Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU

  2022cited by this paper
• Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents

  2022cited by this paper
• ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata.

  2022cited by this paper
• Azole-Resistant Alleles of ERG11 in Candida glabrata Trigger Activation of the Pdr1 and Upc2A Transcription Factors

  2022cited by this paper
• Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi

  2021cited by this paper
• Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

  2021cited by this paper
• Surface, adhesiveness and virulence aspects of Candida haemulonii species complex.

  2020cited by this paper
• Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.

  2020cited by this paper
• Antifungal Resistance in Candida auris: Molecular Determinants

  2020cited by this paper
• Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance

  2020cited by this paper
• Candida haemulonii Complex Species , Brazil , January 2010 – March 2015

  2019cited by this paper
• Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing

  2019cited by this paper
• Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata

  2019cited by this paper
• A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

  2018cited by this paper
• Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

  2018cited by this paper
• Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance

  2018cited by this paper
• Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata

  2018cited by this paper
• Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.

  2018cited by this paper
• Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside

  2018cited by this paper
• Internal validation of GPS™ MONODOSE CanAur dtec‐qPCR kit following the UNE/EN ISO/IEC 17025:2005 for detection of the emerging yeast Candida auris

  2018cited by this paper
• Echinocandin resistance among Candida isolates at an academic medical centre 2005–15: analysis of trends and outcomes

  2018cited by this paper
• Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification

  2018cited by this paper
• Adaptive Mistranslation Accelerates the Evolution of Fluconazole Resistance and Induces Major Genomic and Gene Expression Alterations in Candida albicans

  2017cited by this paper
• Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata

  2017cited by this paper
• Planktonic growth and biofilm formation profiles in Candida haemulonii species complex.

  2017cited by this paper
• The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination

  2017cited by this paper
• Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

  2017cited by this paper
• Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia.

  2016cited by this paper
• Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil

  2016cited by this paper
• Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68‐year‐old man: the first case report and literature review

  2016cited by this paper
• Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction

  2016cited by this paper
• Candida haemulonii Complex Species, Brazil, January 2010–March 2015

  2016cited by this paper
• Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.

  2015cited by this paper
• The evolution of drug resistance in clinical isolates of Candida albicans

  2015cited by this paper
• Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts

  2012cited by this paper
• Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata

  2012cited by this paper
• Genetic control of Candida albicans biofilm development

  2011cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

  2008cited by this paper
• Anidulafungin: a novel echinocandin.

  2006cited by this paper

• Silent Outbreaks of Candida duobushaemulonii in a Pediatric Ward in Brazil

  2026cites this paper